Pharmaceutical companies in the United States by days to cover

Short interest at FINRA's latest settlement date divided by FINRA's average daily volume: the days of normal trading it would take short sellers to buy back. No volume, no figure.

Rhythm Pharmaceuticals leads the 44 pharmaceutical companies in the United States ranked by days to cover, at 23.3, ahead of TG Therapeutics (18.9) and Protagonist Therapeutics (16.9). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report.

Key facts

Companies ranked
44
First
Rhythm Pharmaceuticals23.3
Median
6.7
Combined market value
$3.74T
Countries
1

Market values as of .

United States
All sectors
Pharmaceuticals
USD
Clear filters
Pharmaceutical companies in the United States by days to cover
#CompanyDays to cover ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Rhythm PharmaceuticalsRYTM · Health Care23.3$8.1B$116.80 1.88% down 18% up United States
2TG TherapeuticsTGTX · Health Care18.9$9.8B$64.88 1.88% down 117% up United States
3Protagonist TherapeuticsPTGX · Health Care16.9$8.1B$124.02 2.47% down 51% up United States
4CytokineticsCYTK · Health Care14.2$7.2B$51.46 0.27% up 19% down United States
5Spyre TherapeuticsSYRE · Health Care12.7$9.3B$97.63 3.77% down 332% up United States
6Mirum PharmaceuticalsMIRM · Health Care11.8$6.2B$95.51 3.27% up 34% up United States
7Ligand PharmaceuticalsLGND · Health Care10.5$5.7B$286.94 3.94% down 50% up United States
8Dianthus TherapeuticsDNTH · Health Care10.1$4.8B$84.83 1.01% up 108% up United States
9Belite BioBLTE · Health Care10.0$6.1B$151.02 3.33% down 43% up United States
10Edgewise TherapeuticsEWTX · Health Care9.6$4.5B$41.17 0.48% down 86% up United States
11Summit TherapeuticsSMMT · Health Care9.4$8.5B$10.57 0.67% up 36% down United States
12ErascaERAS · Health Care8.9$5B$14.22 3.34% up 395% up United States
13Praxis Precision MedicinesPRAX · Health Care8.7$8.7B$310.90 1.87% up 86% up United States
14Cogent BiosciencesCOGT · Health Care8.7$4.8B$27.74 0.25% down 20% down United States
15Arrowhead PharmaceuticalsARWR · Health Care8.5$6.2B$43.65 1.25% up 13% up United States
16Ionis PharmaceuticalsIONS · Health Care8.4$4.5B$27.22 0.62% down 63% down United States
17Corcept TherapeuticsCORT · Health Care8.1$7.1B$64.98 4.15% down 10% down United States
18Madrigal PharmaceuticalsMDGL · Health Care7.6$9.2B$396.74 0.34% down 27% down United States
19PTC TherapeuticsPTCT · Health Care7.5$4.9B$58.33 3.16% down 21% down United States
20Elanco Animal HealthELAN · Health Care7.2$13.1B$26.29 1.54% down 26% up United States
21Oruka TherapeuticsORKA · Health Care7.1$6.6B$97.57 1.91% up 255% up United States
22BridgeBio PharmaBBIO · Health Care7.1$15.2B$78.18 0.22% up 21% up United States
23Legend BiotechLEGN · Health Care6.3$3.1B$16.10 0.92% down 41% down United States
24Definium TherapeuticsDFTX · Health Care5.8$4B$29.48 1.24% up 168% up United States
25BioMarin PharmaceuticalBMRN · Health Care5.8$11.9B$61.42 0.02% down 17% up United States
26VeradermicsMANE · Health Care5.1$5.2B$124.39 0.38% down 231% up United States
27ZoetisZTS · Health Care4.8$32.8B$80.79 5.59% down 26% down United States
28Travere TherapeuticsTVTX · Health Care4.7$4.6B$48.30 3.86% down 45% up United States
29PfizerPFE · Health Care4.6$157B$27.54 1.85% down 15% up United States
30Bristol-Myers SquibbBMY · Health Care4.2$119.3B$58.34 2.05% down 30% up United States
31ViatrisVTRS · Health Care4.0$22.8B$19.88 1.97% down 99% up United States
32Royalty PharmaRPRX · Health Care4.0$38.9B$67.72 1.38% down 79% up United States
33InsmedINSM · Health Care3.6$31.7B$144.46 20.58% up 40% down United States
34United TherapeuticsUTHR · Health Care3.5$23.8B$559.10 3.16% down 22% up United States
35Vertex PharmaceuticalsVRTX · Health Care3.4$132B$520.66 2.94% down 27% up United States
36Axsome TherapeuticsAXSM · Health Care3.3$7.1B$135.68 1.25% up 6% down United States
37AbbVieABBV · Health Care3.3$501.2B$283.54 0.86% down 25% up United States
38Amneal PharmaceuticalsAMRX · Health Care2.8$7.5B$21.39 2.24% down 90% up United States
39Regeneron PharmaceuticalsREGN · Health Care2.7$95.5B$923.34 2.35% down 28% up United States
40Eli LillyLLY · Health Care2.7$1.20T$1,351.12 2.29% down 33% up United States
41Johnson & JohnsonJNJ · Health Care2.4$643.1B$267.14 2.04% down 34% up United States
42Merck & CoMRK · Health Care2.4$327.4B$132.81 3.61% down 45% up United States
43Abbott LaboratoriesABT · Health Care1.9$179.9B$103.87 0.58% down 16% down United States
44Alnylam PharmaceuticalsALNY · Health Care1.9$19.8B$147.82 1.06% down 66% down United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. Days to cover is short interest divided by FINRA's average daily volume for the period, worked out here: FINRA's own printed figure is floored at 1 and capped at 999.99, so it is not used. A company with no average volume reported has no days to cover and is not ranked.

Questions and answers

Which pharmaceutical companies in the United States rank first by days to cover?

Rhythm Pharmaceuticals (23.3), TG Therapeutics (18.9) and Protagonist Therapeutics (16.9) are the top three of the 44 pharmaceutical companies in the United States ranked by days to cover as of the 30 Oct 2026 settlement date.

How many pharmaceutical companies in the United States are in this ranking?

44 are ranked by days to cover.

What are these pharmaceutical companies in the United States worth together?

The 44 pharmaceutical companies in the United States ranked by days to cover have a combined market value of $3.74T as of the 30 Oct 2026 settlement date.

What does ranking by days to cover measure?

Short interest at FINRA's latest settlement date divided by FINRA's average daily volume: the days of normal trading it would take short sellers to buy back. No volume, no figure.

Cite this page

Funkfolio, “Pharmaceutical companies in the United States by days to cover”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=days-to-cover

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.